3-112605719-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_199511.3(CCDC80):āc.2551A>Gā(p.Lys851Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000112 in 1,614,246 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000026 ( 0 hom., cov: 33)
Exomes š: 0.0000096 ( 0 hom. )
Consequence
CCDC80
NM_199511.3 missense
NM_199511.3 missense
Scores
6
13
Clinical Significance
Conservation
PhyloP100: 4.95
Genes affected
CCDC80 (HGNC:30649): (coiled-coil domain containing 80) Predicted to enable glycosaminoglycan binding activity. Predicted to act upstream of or within extracellular matrix organization; positive regulation of cell-substrate adhesion; and response to bacterium. Predicted to be located in extracellular matrix. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.1855641).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCDC80 | NM_199511.3 | c.2551A>G | p.Lys851Glu | missense_variant | 8/8 | ENST00000206423.8 | |
CCDC80 | NM_199512.3 | c.2551A>G | p.Lys851Glu | missense_variant | 8/8 | ||
CCDC80 | XM_047447495.1 | c.2584A>G | p.Lys862Glu | missense_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCDC80 | ENST00000206423.8 | c.2551A>G | p.Lys851Glu | missense_variant | 8/8 | 1 | NM_199511.3 | P1 | |
CCDC80 | ENST00000439685.6 | c.2551A>G | p.Lys851Glu | missense_variant | 8/8 | 1 | P1 | ||
CCDC80 | ENST00000461431.1 | c.664A>G | p.Lys222Glu | missense_variant | 6/6 | 3 | |||
CCDC80 | ENST00000479368.1 | c.385A>G | p.Lys129Glu | missense_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152242Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
4
AN:
152242
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251132Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135720
GnomAD3 exomes
AF:
AC:
5
AN:
251132
Hom.:
AF XY:
AC XY:
4
AN XY:
135720
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461886Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 727246
GnomAD4 exome
AF:
AC:
14
AN:
1461886
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152360Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74504
GnomAD4 genome
AF:
AC:
4
AN:
152360
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
4
Asia WGS
AF:
AC:
1
AN:
3476
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 05, 2022 | The c.2551A>G (p.K851E) alteration is located in exon 8 (coding exon 7) of the CCDC80 gene. This alteration results from a A to G substitution at nucleotide position 2551, causing the lysine (K) at amino acid position 851 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Uncertain
D;D;.
Polyphen
P;P;.
Vest4
MutPred
Loss of methylation at K851 (P = 0.0115);Loss of methylation at K851 (P = 0.0115);.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at